Guidance of B Cells by the Orphan G Protein-Coupled Receptor EBI2 Shapes Humoral Immune Responses

Immunity

Volumn 31, Issue 2, 2009, Pages 259-269

  Gatto, Dominique ^a   Paus, Didrik ^b   Basten, Antony ^a,c   Mackay, Charles R ^a,c   Brink, Robert ^a,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR EBI2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMORAL IMMUNITY; LYMPH FOLLICLE; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL MOVEMENT; CHEMOTAXIS; CYTOKINES; DOWN-REGULATION; GERMINAL CENTER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, G-PROTEIN-COUPLED; T-LYMPHOCYTES;

EID: 68649108084     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.06.016     Document Type: Article

References (41)

1. Aalto Y., El-Rifa W., Vilpo L., Ollila J., Nagy B., Vihinen M., Vilpo J., and Knuutila S. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 15 (2001) 1721-1728
2. Allen C.D., Ansel K.M., Low C., Lesley R., Tamamura H., Fujii N., and Cyster J.G. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5 (2004) 943-952
3. Benned-Jensen T., and Rosenkilde M.M. Structural motifs of importance for the constitutive activity of the orphan 7TM receptor EBI2: Analysis of receptor activation in the absence of an agonist. Mol. Pharmacol. 74 (2008) 1008-1021
4. Benson M.J., Erickson L.D., Gleeson M.W., and Noelle R.J. Affinity of antigen encounter and other early B-cell signals determine B-cell fate. Curr. Opin. Immunol. 19 (2007) 275-280
5. Birkenbach M., Josefsen K., Yalamanchili R., Lenoir G., and Kieff E. Epstein-Barr virus-induced genes: First lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67 (1993) 2209-2220
6. Brink R., Phan T.G., Paus D., and Chan T.D. Visualizing the effects of antigen affinity on T-dependent B-cell differentiation. Immunol. Cell Biol. 86 (2008) 31-39
7. Campbell D.J., Kim C.H., and Butcher E.C. Chemokines in the systemic organization of immunity. Immunol. Rev. 195 (2003) 58-71
8. Chan T.D., Gatto D., Wood K., Camidge T., Basten A., and Brink R. Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J. Immunol. (2009) in press
9. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., and Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87 (1996) 1037-1047
10. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., and Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
11. Garcia De Vinuesa C., Gulbranson-Judge A., Khan M., O'Leary P., Cascalho M., Wabl M., Klaus G.G., Owen M.J., and MacLennan I.C. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29 (1999) 3712-3721
12. Glynne R., Ghandour G., Rayner J., Mack D.H., and Goodnow C.C. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176 (2000) 216-246
13. Hargreaves D.C., Hyman P.L., Lu T.T., Ngo V.N., Bidgol A., Suzuki G., Zou Y.R., Littman D.R., and Cyster J.G. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194 (2001) 45-56
14. Jacob J., Kassir R., and Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173 (1991) 1165-1175
15. Kallies A., Hasbold J., Tarlinton D.M., Dietrich W., Corcoran L.M., Hodgkin P.D., and Nutt S.L. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200 (2004) 967-977
16. Kelsoe G., and Zheng B. Sites of B-cell activation in vivo. Curr. Opin. Immunol. 5 (1993) 418-422
17. Lam L.T., Wright G., Davis R.E., Lenz G., Farinha P., Dang L., Chan J.W., Rosenwald A., Gascoyne R.D., and Staudt L.M. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 111 (2008) 3701-3713
18. Levoye A., Dam J., Ayoub M.A., Guillaume J.L., and Jockers R. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep. 7 (2006) 1094-1098
19. Lewandoski M., Wassarman K.M., and Martin G.R. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr. Biol. 7 (1997) 148-151
20. Liu Y.J., Zhang J., Lane P.J., Chan E.Y., and MacLennan I.C. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21 (1991) 2951-2962
21. MacLennan I.C. Germinal centers. Annu. Rev. Immunol. 12 (1994) 117-139
22. MacLennan I.C., Toellner K.M., Cunningham A.F., Serre K., Sze D.M., Zuniga E., Cook M.C., and Vinuesa C.G. Extrafollicular antibody responses. Immunol. Rev. 194 (2003) 8-18
23. Manz R.A., Hauser A.E., Hiepe F., and Radbruch A. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23 (2005) 367-386
24. Mohr E., Serre K., Manz R.A., Cunningham A.F., Khan M., Hardie D.L., Bird R., and MacLennan I.C. Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J. Immunol. 182 (2009) 2113-2123
25. Nie Y., Waite J., Brewer F., Sunshine M.J., Littman D.R., and Zou Y.R. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200 (2004) 1145-1156
26. Niedobitek G., Herbst H., Young L.S., Brooks L., Masucci M.G., Crocker J., Rickinson A.B., and Stein H. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79 (1992) 2520-2526
27. O'Connor B.P., Gleeson M.W., Noelle R.J., and Erickson L.D. The rise and fall of long-lived humoral immunity: Terminal differentiation of plasma cells in health and disease. Immunol. Rev. 194 (2003) 61-76
28. Okada T., and Cyster J.G. B cell migration and interactions in the early phase of antibody responses. Curr. Opin. Immunol. 18 (2006) 278-285
29. Paus D., Phan T.G., Chan T.D., Gardam S., Basten A., and Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203 (2006) 1081-1091
30. Phan T.G., Amesbury M., Gardam S., Crosbie J., Hasbold J., Hodgkin P.D., Basten A., and Brink R. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197 (2003) 845-860
31. Phan T.G., Gardam S., Basten A., and Brink R. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J. Immunol. 174 (2005) 4567-4578
32. Reif K., Ekland E.H., Ohl L., Nakano H., Lipp M., Forster R., and Cyster J.G. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416 (2002) 94-99
33. Rodriguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., and Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25 (2000) 139-140
34. Rosenkilde M.M., Benned-Jensen T., Andersen H., Holst P.J., Kledal T.N., Luttichau H.R., Larsen J.K., Christensen J.P., and Schwartz T.W. Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J. Biol. Chem. 281 (2006) 13199-13208
35. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22 (2004) 891-928
36. Seo S.J., Fields M.L., Buckler J.L., Reed A.J., Mandik-Nayak L., Nish S.A., Noelle R.J., Turka L.A., Finkelman F.D., Caton A.J., and Erikson J. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16 (2002) 535-546
37. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., and Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13 (2000) 199-212
38. Surgand J.S., Rodrigo J., Kellenberger E., and Rognan D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62 (2006) 509-538
39. Swift S., Lorens J., Achacoso P., and Nolan G.P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr. Protoc. Immunol. Chapter 10 (2001) Unit 10.17C
40. William J., Euler C., Christensen S., and Shlomchik M.J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297 (2002) 2066-2070
41. Ye S., Pang H., Gu Y.Y., Hua J., Chen X.G., Bao C.D., Wang Y., Zhang W., Qian J., Tsao B.P., et al. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology 42 (2003) 1155-1163